Maria Taís de Moura Fontes Araújo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Taís de Moura Fontes Araújo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ana Edileia Barbosa Pereira Leal
Postgraduate Program in Biotechnology, State University of Feira de Santana, Feira de Santana, Brazil
1 shared publication - Cristiane dos Santos Cerqueira Alves
Center For Studies and Research of Medicinal Plants, Federal University of San Francisco Valley, Petrolina, Brazil
1 shared publication - Jackson Roberto Guedes da Silva Almeida
Universidade Federal do Vale do São Francisco, Brasil
1 shared publication - Jackson de Menezes Barbosa
Center For Studies and Research of Medicinal Plants, Federal University of San Francisco Valley, Petrolina, Brazil
1 shared publication - Raimundo Gonçalves de Oliveira Júnior
Universite Paris Cite
1 shared publication Ádley Antonini Neves de Lima
Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
1 shared publication
Latest Publications
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (28) , 2315-2328
Pharmacological Activities of the Genus Passiflora (Passifloraceae): A Patent Review
Background: Passiflora L. is a genus belonging to the Passifloraceae family, with many species widely used in folk medicine and several pharmacological activities described in the scien-tific literature, being a major target for the development of new therapeutic products. Studies have identified several bioactive compounds in their composition as responsible for these activities, mainly C-glycoside flavonoids. Objective: The aim of this study was to carry out a review of patents related to the genus and its ap-plication in several pharmacological activities, important for the development of new drugs and formulations. Method: The search was carried out in 5 specialized databases, INPI, EPO, WIPO, Latipat and Derwent, using the term ‘Passiflora’ combined with ‘A61K and A61P', subclasses of section A of the International Patent Classification (IPC), which are destined to medical, dental or hygienic pur-poses, and therapeutic activity of chemical compounds or medicinal preparation, respectively. Results: 1,198 patents citing the genus in the title or abstract have been found, 508 being duplicates. After exclusion and inclusion criteria, 23 patents written in English, Portuguese and Spanish were selected, which demonstrated biological assays in vivo with species of Passiflora as the only active constituent or incorporated in formulations with other compounds. Conclusion: The findings of this search showed growing interest in research and industrial areas in the pharmaceutical development with species of Passiflora, suggesting that the different bioactive compounds present in the genus can be considered as an important tool for the development of new effective and safe products with pharmacological potential.
- 1 November 2022
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (28) , 2315-2328
Pharmacological Activities of the Genus Passiflora (Passifloraceae): A Patent Review
Background: Passiflora L. is a genus belonging to the Passifloraceae family, with many species widely used in folk medicine and several pharmacological activities described in the scien-tific literature, being a major target for the development of new therapeutic products. Studies have identified several bioactive compounds in their composition as responsible for these activities, mainly C-glycoside flavonoids. Objective: The aim of this study was to carry out a review of patents related to the genus and its ap-plication in several pharmacological activities, important for the development of new drugs and formulations. Method: The search was carried out in 5 specialized databases, INPI, EPO, WIPO, Latipat and Derwent, using the term ‘Passiflora’ combined with ‘A61K and A61P', subclasses of section A of the International Patent Classification (IPC), which are destined to medical, dental or hygienic pur-poses, and therapeutic activity of chemical compounds or medicinal preparation, respectively. Results: 1,198 patents citing the genus in the title or abstract have been found, 508 being duplicates. After exclusion and inclusion criteria, 23 patents written in English, Portuguese and Spanish were selected, which demonstrated biological assays in vivo with species of Passiflora as the only active constituent or incorporated in formulations with other compounds. Conclusion: The findings of this search showed growing interest in research and industrial areas in the pharmaceutical development with species of Passiflora, suggesting that the different bioactive compounds present in the genus can be considered as an important tool for the development of new effective and safe products with pharmacological potential.